New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Profound Medical Corp.
PROF
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

188M

Medical - Devices

Next Earning date - 07 Nov 2024

188M

Medical - Devices

Next Earning date - 07 Nov 2024

7.69USD
Shape0.17 ( 2.26%)
favorite-chart

Relative Strenght

15
favorite-chart

Volume Buzz

-52%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

34%

Quote Panel

Shape
Updated October 12, 2024
1W 1.45 % 1M -0.39 % 3M -15.96 % 1Y -17.31 %

Key Metrics

Shape
  • Market Cap

    188.27M


  • Shares Outstanding

    24.48M


  • Share in Float

    20.93M


  • Dividende

    0


  • Earning Date

    07 Nov 2024


  • Price Target

    7.69


  • Average Volume

    52320


  • Beta

    0.805


  • Range

    7.11-11.69


  • Industry

    Medical - Devices


  • Website

    https://www.profoundmedical.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

23.75x

P/S Ratio

4.79x

P/B Ratio

0.2

Debt/Equity

-350.8%

Net Margin

$-1.2

EPS

How PROF compares to sector?

P/E Ratio

Relative Strength

Shape

PROF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$27M

Shape1122%

2025-Revenue

$1.19

Shape-323%

2025-EPS

$27M

Shape-262%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Raymond James

downgrade

Previous: Not converted

2022-02-22

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.24
vs -0.29

Q4.22

arrow
arrow

N/A

-0.46
vs -0.49

Q1.23

arrow
arrow

N/A

-0.32
vs -0.40

Q2.23

arrow
arrow

N/A

-0.35
vs -0.28

Q3.23

arrow
arrow

N/A

-0.26
vs -0.24

Q4.23

arrow
arrow

N/A

-0.42
vs -0.46

Q1.24

arrow
arrow

N/A

-0.26
vs -0.32

Q2.24

arrow
arrow

N/A

-0.28
vs -0.35

Q3.24

arrow
arrow

N/A

-0.40
vs -0.26

Q4.24

arrow
arrow

N/A

-0.41
vs -0.42

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

-20%

2M  vs 2.5M

Q4.22

arrow
arrow

+26%

1.3M  vs 998K

Q1.23

arrow
arrow

+36%

1.9M  vs 1.4M

Q2.23

arrow
arrow

-21%

1.6M  vs 2M

Q3.23

arrow
arrow

-15%

1.7M  vs 2M

Q4.23

arrow
arrow

+64%

2.1M  vs 1.3M

Q1.24

arrow
arrow

+2%

1.9M  vs 1.9M

Q2.24

arrow
arrow

+39%

2.2M  vs 1.6M

Q3.24

arrow
arrow

+77%

3.1M  vs 1.7M

Q4.24

arrow
arrow

+96%

4M  vs 2.1M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-8%

-0.08
vs -0.09

Q4.22

arrow
arrow

-18%

-0.18
vs -0.08

Q1.23

arrow
arrow

-14%

-0.14
vs -0.18

Q2.23

arrow
arrow

-17%

-0.17
vs -0.14

Q3.23

arrow
arrow

-14%

-0.14
vs -0.17

Q4.23

arrow
arrow

-30%

-0.30
vs -0.14

Q1.24

arrow
arrow

-13%

-0.13
vs -0.30

Q2.24

arrow
arrow

-18%

-0.18
vs -0.13

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

37

37
vs 42

-12%

Q4.22

arrow
arrow

37

37
vs 37

NA

Q1.23

arrow
arrow

35

35
vs 37

-5%

Q2.23

arrow
arrow

34

34
vs 35

-3%

Q3.23

arrow
arrow

34

34
vs 34

NA

Q4.23

arrow
arrow

46

46
vs 34

35%

Q1.24

arrow
arrow

44

44
vs 46

-4%

Q2.24

arrow
arrow

40

40
vs 44

-9%

Earnings Growth

Latest News